Elimination of perinatal hepatitis B

Providing the first vaccine dose within 24 hours of birth

COMMITTEE ON INFECTIOUS DISEASES, COMMITTEE ON FETUS AND NEWBORN

Research output: Contribution to journalArticle

Abstract

After the introduction of the hepatitis B vaccine in the United States in 1982, a greater than 90% reduction in new infections was achieved. However, approximately 1000 new cases of perinatal hepatitis B infection are still identified annually in the United States. Prevention of perinatal hepatitis B relies on the proper and timely identification of infants born to mothers who are hepatitis B surface antigen positive and to mothers with unknown status to ensure administration of appropriate postexposure immunoprophylaxis with hepatitis B vaccine and immune globulin. To reduce the incidence of perinatal hepatitis B transmission further, the American Academy of Pediatrics endorses the recommendation of the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention that all newborn infants with a birth weight of greater than or equal to 2000 g receive hepatitis B vaccine by 24 hours of age.

Original languageEnglish (US)
Article numbere20171870
JournalPediatrics
Volume140
Issue number3
DOIs
StatePublished - Sep 1 2017

Fingerprint

Hepatitis B Vaccines
Hepatitis B
Vaccines
Parturition
Mothers
Advisory Committees
Centers for Disease Control and Prevention (U.S.)
Hepatitis B Surface Antigens
Infection
Birth Weight
Immunoglobulins
Immunization
Newborn Infant
Pediatrics
Incidence

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

COMMITTEE ON INFECTIOUS DISEASES, COMMITTEE ON FETUS AND NEWBORN (2017). Elimination of perinatal hepatitis B: Providing the first vaccine dose within 24 hours of birth. Pediatrics, 140(3), [e20171870]. https://doi.org/10.1542/peds.2017-1870

Elimination of perinatal hepatitis B : Providing the first vaccine dose within 24 hours of birth. / COMMITTEE ON INFECTIOUS DISEASES, COMMITTEE ON FETUS AND NEWBORN.

In: Pediatrics, Vol. 140, No. 3, e20171870, 01.09.2017.

Research output: Contribution to journalArticle

COMMITTEE ON INFECTIOUS DISEASES, COMMITTEE ON FETUS AND NEWBORN 2017, 'Elimination of perinatal hepatitis B: Providing the first vaccine dose within 24 hours of birth', Pediatrics, vol. 140, no. 3, e20171870. https://doi.org/10.1542/peds.2017-1870
COMMITTEE ON INFECTIOUS DISEASES, COMMITTEE ON FETUS AND NEWBORN. Elimination of perinatal hepatitis B: Providing the first vaccine dose within 24 hours of birth. Pediatrics. 2017 Sep 1;140(3). e20171870. https://doi.org/10.1542/peds.2017-1870
COMMITTEE ON INFECTIOUS DISEASES, COMMITTEE ON FETUS AND NEWBORN. / Elimination of perinatal hepatitis B : Providing the first vaccine dose within 24 hours of birth. In: Pediatrics. 2017 ; Vol. 140, No. 3.
@article{24346e9101f849f69d75315f007ee8df,
title = "Elimination of perinatal hepatitis B: Providing the first vaccine dose within 24 hours of birth",
abstract = "After the introduction of the hepatitis B vaccine in the United States in 1982, a greater than 90{\%} reduction in new infections was achieved. However, approximately 1000 new cases of perinatal hepatitis B infection are still identified annually in the United States. Prevention of perinatal hepatitis B relies on the proper and timely identification of infants born to mothers who are hepatitis B surface antigen positive and to mothers with unknown status to ensure administration of appropriate postexposure immunoprophylaxis with hepatitis B vaccine and immune globulin. To reduce the incidence of perinatal hepatitis B transmission further, the American Academy of Pediatrics endorses the recommendation of the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention that all newborn infants with a birth weight of greater than or equal to 2000 g receive hepatitis B vaccine by 24 hours of age.",
author = "{COMMITTEE ON INFECTIOUS DISEASES, COMMITTEE ON FETUS AND NEWBORN} and Kristi Watterberg and William Benitz and Ivan Hand and Eric Eichenwald and Brenda Poindexter and Stewart, {Dan L.} and Aucott, {Susan W} and Puopolo, {Karen M.} and Goldsmith, {Jay P.} and Wang, {Kasper S.} and Thierry Lacaze and Mascola, {Maria Ann} and Raju, {Tonse N.K.} and Barfield, {Wanda D.} and Erin Keels and Jim Couto and Byington, {Carrie L.} and Maldonado, {Yvonne A.} and {Barnett Md}, {Elizabeth D.} and Campbell, {James D.} and Davies, {H. Dele} and Ruth Lynfield and Munoz, {Flor M.} and Dawn Nolt and Nyquist, {Ann Christine} and Sean O'Leary and Rathore, {Mobeen H.} and Sawyer, {Mark H.} and Steinbach, {William J.} and Tan, {Tina Q.} and Zaoutis, {Theoklis E.} and Kimberlin, {David W.} and Brady, {Michael T.} and Jackson, {Mary Anne} and Long, {Sarah S.} and Bernstein, {Henry H.} and Meissner, {H. Cody} and Douglas Campos-Outcalt and Cohn, {Amanda C.} and Farizo, {Karen M.} and Marc Fischer and Gellin, {Bruce G.} and Gorman, {Richard L.} and Natasha Halasa and Robinson, {Joan L.} and Jamie Deseda-Tous and Simon, {Geoffrey R.} and Starke, {Jeffrey R.} and Frantz, {Jennifer M.}",
year = "2017",
month = "9",
day = "1",
doi = "10.1542/peds.2017-1870",
language = "English (US)",
volume = "140",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "3",

}

TY - JOUR

T1 - Elimination of perinatal hepatitis B

T2 - Providing the first vaccine dose within 24 hours of birth

AU - COMMITTEE ON INFECTIOUS DISEASES, COMMITTEE ON FETUS AND NEWBORN

AU - Watterberg, Kristi

AU - Benitz, William

AU - Hand, Ivan

AU - Eichenwald, Eric

AU - Poindexter, Brenda

AU - Stewart, Dan L.

AU - Aucott, Susan W

AU - Puopolo, Karen M.

AU - Goldsmith, Jay P.

AU - Wang, Kasper S.

AU - Lacaze, Thierry

AU - Mascola, Maria Ann

AU - Raju, Tonse N.K.

AU - Barfield, Wanda D.

AU - Keels, Erin

AU - Couto, Jim

AU - Byington, Carrie L.

AU - Maldonado, Yvonne A.

AU - Barnett Md, Elizabeth D.

AU - Campbell, James D.

AU - Davies, H. Dele

AU - Lynfield, Ruth

AU - Munoz, Flor M.

AU - Nolt, Dawn

AU - Nyquist, Ann Christine

AU - O'Leary, Sean

AU - Rathore, Mobeen H.

AU - Sawyer, Mark H.

AU - Steinbach, William J.

AU - Tan, Tina Q.

AU - Zaoutis, Theoklis E.

AU - Kimberlin, David W.

AU - Brady, Michael T.

AU - Jackson, Mary Anne

AU - Long, Sarah S.

AU - Bernstein, Henry H.

AU - Meissner, H. Cody

AU - Campos-Outcalt, Douglas

AU - Cohn, Amanda C.

AU - Farizo, Karen M.

AU - Fischer, Marc

AU - Gellin, Bruce G.

AU - Gorman, Richard L.

AU - Halasa, Natasha

AU - Robinson, Joan L.

AU - Deseda-Tous, Jamie

AU - Simon, Geoffrey R.

AU - Starke, Jeffrey R.

AU - Frantz, Jennifer M.

PY - 2017/9/1

Y1 - 2017/9/1

N2 - After the introduction of the hepatitis B vaccine in the United States in 1982, a greater than 90% reduction in new infections was achieved. However, approximately 1000 new cases of perinatal hepatitis B infection are still identified annually in the United States. Prevention of perinatal hepatitis B relies on the proper and timely identification of infants born to mothers who are hepatitis B surface antigen positive and to mothers with unknown status to ensure administration of appropriate postexposure immunoprophylaxis with hepatitis B vaccine and immune globulin. To reduce the incidence of perinatal hepatitis B transmission further, the American Academy of Pediatrics endorses the recommendation of the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention that all newborn infants with a birth weight of greater than or equal to 2000 g receive hepatitis B vaccine by 24 hours of age.

AB - After the introduction of the hepatitis B vaccine in the United States in 1982, a greater than 90% reduction in new infections was achieved. However, approximately 1000 new cases of perinatal hepatitis B infection are still identified annually in the United States. Prevention of perinatal hepatitis B relies on the proper and timely identification of infants born to mothers who are hepatitis B surface antigen positive and to mothers with unknown status to ensure administration of appropriate postexposure immunoprophylaxis with hepatitis B vaccine and immune globulin. To reduce the incidence of perinatal hepatitis B transmission further, the American Academy of Pediatrics endorses the recommendation of the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention that all newborn infants with a birth weight of greater than or equal to 2000 g receive hepatitis B vaccine by 24 hours of age.

UR - http://www.scopus.com/inward/record.url?scp=85028730762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028730762&partnerID=8YFLogxK

U2 - 10.1542/peds.2017-1870

DO - 10.1542/peds.2017-1870

M3 - Article

VL - 140

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 3

M1 - e20171870

ER -